Document is current
Any future updates will be listed below
-
Authors
Juel, Caroline T. B.
Lund, Asger
Andersen, Maria M.
Hansen, Carsten P.
Storkholm, Jan H.
Rehfeld, Jens F.
van Hall, Gerrit
Hartmann, Bolette
Wewer Albrechtsen, Nicolai J.
Holst, Jens J.
Vilsbøll, Tina
Knop, Filip K. https://orcid.org/0000-0002-2495-5034
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 25 November 2019
Accepted: 11 March 2020
First Online: 11 May 2020
Duality of interest
: FKK has received lecture fees from, participated in advisory boards of, consulted for and/or received research grants from Sanofi (the manufacturer of lixisenatide) and Zealand Pharma (the inventor of lixisenatide). The remaining authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Free to read: This content has been made available to all.
